Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? Reply

Daniel Kotz^*, Wolfgang Viechtbauer, Colin Simpson, Onno C. P. van Schayck, Robert West, Aziz Sheikh

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

98 Downloads (Pure)

Original language	English
Pages (from-to)	E40-E42
Journal	The Lancet Respiratory medicine
Volume	3
Issue number	12
DOIs	https://doi.org/10.1016/S2213-2600(15)00470-1
Publication status	Published - Dec 2015

Access to Document

@article{42e76f5b9d6e4373a0f202335f663fff,

title = "Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? Reply",

author = "Daniel Kotz and Wolfgang Viechtbauer and Colin Simpson and {van Schayck}, {Onno C. P.} and Robert West and Aziz Sheikh",

year = "2015",

month = dec,

doi = "10.1016/S2213-2600(15)00470-1",

language = "English",

volume = "3",

pages = "E40--E42",

journal = "The Lancet Respiratory medicine",

issn = "2213-2600",

publisher = "ELSEVIER SCI LTD",

number = "12",

}

TY - JOUR

T1 - Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? Reply

AU - Kotz, Daniel

AU - Viechtbauer, Wolfgang

AU - Simpson, Colin

AU - van Schayck, Onno C. P.

AU - West, Robert

AU - Sheikh, Aziz

PY - 2015/12

Y1 - 2015/12

U2 - 10.1016/S2213-2600(15)00470-1

DO - 10.1016/S2213-2600(15)00470-1

M3 - Article

SN - 2213-2600

VL - 3

SP - E40-E42

JO - The Lancet Respiratory medicine

JF - The Lancet Respiratory medicine

IS - 12

ER -